A national survey on the effect of pharmaceutical promotion on medical students

Medical Teacher

Volumn 26, Issue 7, 2004, Pages 630-634

  Vainiomäki, Maija ^a   Helve, Otto ^b   Vuorenkoski, Lauri ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; DRUG MARKETING; FEMALE; FINLAND; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL STUDENT; PHYSICIAN ATTITUDE; PRESCRIPTION; QUESTIONNAIRE;

EMPIRICAL APPROACH; HEALTH CARE AND PUBLIC HEALTH;

ATTITUDE TO HEALTH; DATA COLLECTION; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUG UTILIZATION; ETHICS, MEDICAL; FEMALE; FINLAND; HUMANS; INTERINSTITUTIONAL RELATIONS; INTERPROFESSIONAL RELATIONS; MALE; MARKETING; QUESTIONNAIRES; STUDENTS, MEDICAL;

EID: 12344320643     PISSN: 0142159X     EISSN: None     Source Type: Journal    
DOI: 10.1080/01421590400004890     Document Type: Article

References (15)

1. Armstrong, D., Reyburn, H. & Jones, R. (1996) A study of general practitioners' reasons for changing their prescribing behaviour, British Medical Journal, 312, pp. 949-952.
2. Helin, A., Hoppu, K. & Klaukka, T. (1998) Lääkehoidon ongelmia lääkärin näkökulmasta (Physicians' view of the problems of pharmaceutical treatment], Suomen Lä äkärilehti 36, pp. 4235-4240.
3. Hodges, B. (1995) Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks, Canadian Medical Association Journal, 153, pp. 553-559.
4. Lexchin, J., Bero, L.A., Djulbegovic, B. & Clark, O. (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review, British Medical Journal, 326, pp. 1167-1170.
5. Mäntyranta, T. & Hemminki, E. (1901) Medical students and drug promotion, Academic Medicine, 69, p. 736.
6. McCormick, B.B., Tomlinson, G., Brill-Edwards, P. & Detsky, A.S. (2001) Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behaviour, Journal of the American Medical Association, 286, pp. 1994-1999.
7. Mick, T. (1991) Pharmaceutical funding and medical students, Journal of the American Medical Association, 265, pp. 659-664.
8. Sandberg, W.S., Carlos, R., Sanoberg, E.H. & Roizen, M.F. (1997) The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products, Academic Medicine, 72, pp. 916-918.
9. Steinman, M.A., Shlipak, M.G. & McPhee, S.J. (2001) Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions, American Journal of Medicine, 110, pp. 551-557.
10. Taylor, R.J. & Bond, C.M. (1991) Change in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice, British Journal of General Practice 41, pp. 244-248.
11. Vinson, D.C., McCandless, B. & Hosokawa, M.C. (1993) Medical students' attitudes toward pharmaceutical marketing: possibilities for change, Family Medicine, 25, pp. 31-33.
12. Watkins, C., Moore, L., Harvey, I., Carthy, P., Robinson, E. & Brawn, R. (2003) Characteristics of general practitioners who frequently see drug industry representatives: a national cross sectional survey, British Medical Journal, 326, pp. 1178-1179.
13. Wazana, A. (2000) Physicians and the pharmaceutical industry: is a gift ever just a gift?, Journal of the American Medical Association, 283, pp. 373-380.
14. Wazana, A. & Primeau, F. (2002) Ethical considerations in the relationship between physicians and the pharmaceutical industry, Psychiatric Clinics of North America, 25, pp. 647-663.
15. Wilkes, M.S. & Hoffman, J.R. (2001) An innovative approach to educating medical students about pharmaceutical promotion, Academic Medicine, 76, pp. 1271-1277.